Touch Biometrix, an investee company within the Deepbridge Technology Growth EIS portfolio, has announced a successful Series B funding round, with plans to launch a FAP60 fingerprint biometric sensor as the first prodct utilising its thin transistor film (TFT) technology with 'active pixels'.
As of the 25th April 2022, Deepbridge Capital is proud to announce that it has deployed a record £31.5 million into early-stage technology and life sciences companies during the 2021/22 tax year, up from £29.4 million in 2020/21.
Sky Medical Technology Ltd., an investee company within the Deepbridge Technology Growth EIS portfolio, announced the availability of its flagship product the geko™ device, on the Government of India e-Marketplace (GeM) procurement portal.
Filisia, an investee company within the Deepbridge Life Sciences EIS portfolio, has been selected to participate in the 'Play For All Accelerator' by The LEGO Foundation.
Sky Medical Technology Ltd., an investee company within the Deepbridge Technology Growth EIS portfolio, announced further U.S. Food and Drug Administration (FDA) 510(k) clearance to market the new (W3) geko™ device variant, for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency and/or ischemia.
Deepbridge are pleased to announce that we have sponsored Louise Burton, a snooker player who is currently ranked 39th in the world by World Women's Snooker and also Administration Executive at Deepbridge.
Louise Burton has competed on the World Women’s Snooker Tour since 2018, most notably reaching the last 16 of her debut event at the Eden Masters.
Deepbridge are pleased to announce that we have sponsored Seb Morris in the Porsche Carrera Cup GB 2022, which continues to be the fastest single marque GT racing series in the country. With its 350th race, the prestigous Porsche Championship returns for its milestone 20th anniversary this year.
